Português

Inglês

Home | Site Map | Add to Favorites Link | Send page to a Friend | Contact us

Relatórios Clínicos

Clinical Trial - Phase I

Objectives: Primary: To determine the toxicity and side effects, of P-MAPA immunomodulator in HIV + individuals. Secondary: To determine the local and systemic effect, if any, of P-MAPA in the individuals.To determine the effect, if any, in the white blood cell count.

Lógica Digital

Privacy Policy | Legal | copyright@2.006-farmabrasilis- all rights reserved